Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/119083
Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
AIM: To investigate whether or not key populations affected by
hepatitis B and hepatitis C are being tested sufficiently for
these diseases throughout the European region. METHODS: We
searched MEDLINE and EMBASE for studies on HBV and HCV testing
in the 53 Member States of the World Health Organization
European Region following PRISMA criteria. RESULTS: 136
English-language studies from 24 countries published between
January 2007 and June 2013 were found. Most studies took place
in 6 countries: France, Germany, Italy, the Netherlands, Turkey,
and the United Kingdom. 37 studies (27%) addressed HBV, 46 (34%)
HCV, and 53 (39%) both diseases. The largest categories of study
populations were people who use drugs (18%) and health care
patient populations (17%). Far fewer studies focused on
migrants, prison inmates, or men who have sex with men.
CONCLUSIONS: The overall evidence base on HBV and HCV testing
has considerable gaps in terms of the countries and populations
represented and validity of testing uptake data. More research
is needed throughout Europe to guide efforts to provide testing
to certain key populations.
Matèries
Matèries (anglès)
Citació
Col·leccions
Citació
LAZARUS, Jeffrey v., SPERLE, Ida, SPINA, Alexander, ROCKSTROH, Jürgen kurt. Are the testing needs of key European populations affected by
hepatitis B and hepatitis C being addressed? A scoping review of
testing studies in Europe. _Croatian Medical Journal_. 2016. Vol. 57, núm. 5, pàgs. 442-456. [consulta: 20 de gener de 2026]. ISSN: 0353-9504. [Disponible a: https://hdl.handle.net/2445/119083]